Phase 3 SELVA study evaluating QTORINâ„¢ rapamycin 3.9% anhydrous gel (QTORINâ„¢ rapamycin) for microcystic lymphatic ...
BLR announced that TrainingToday, its workforce training platform, has been awarded in the Best Advance in Learning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback